Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Pharmacogenomics J ; 13(1): 60-9, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21912425

RESUMO

Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are severe, cutaneous adverse drug reactions that are rare but life threatening. Genetic biomarkers for allopurinol-related SJS/TEN in Japanese were examined in a genome-wide association study in which Japanese patients (n=14) were compared with ethnically matched healthy controls (n=991). Associations between 890 321 single nucleotide polymorphisms and allopurinol-related SJS/TEN were analyzed by the Fisher's exact test (dominant genotype mode). A total of 21 polymorphisms on chromosome 6 were significantly associated with allopurinol-related SJS/TEN. The strongest association was found at rs2734583 in BAT1, rs3094011 in HCP5 and GA005234 in MICC (P=2.44 × 10(-8); odds ratio=66.8; 95% confidence interval, 19.8-225.0). rs9263726 in PSORS1C1, also significantly associated with allopurinol-related SJS/TEN, is in absolute linkage disequilibrium with human leukocyte antigen-B*5801, which is in strong association with allopurinol-induced SJS/TEN. The ease of typing rs9263726 makes it a useful biomarker for allopurinol-related SJS/TEN in Japanese.


Assuntos
Alopurinol/efeitos adversos , Síndrome de Stevens-Johnson/genética , Idoso , Idoso de 80 Anos ou mais , Alopurinol/uso terapêutico , Povo Asiático/genética , Biomarcadores/metabolismo , Cromossomos Humanos Par 6/efeitos dos fármacos , Cromossomos Humanos Par 6/genética , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Feminino , Estudo de Associação Genômica Ampla/métodos , Antígenos HLA/genética , Antígenos HLA/metabolismo , Humanos , Desequilíbrio de Ligação , Masculino , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único , Pele/efeitos dos fármacos , Pele/metabolismo , Pele/patologia , Síndrome de Stevens-Johnson/induzido quimicamente , Síndrome de Stevens-Johnson/etiologia , Síndrome de Stevens-Johnson/metabolismo
2.
Int J Cancer ; 59(4): 538-42, 1994 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-7960224

RESUMO

Although asbestos and erionite are proven human carcinogens, most studies have concluded that these fibres are not mutagenic to mammalian cells in vitro. We have studied the potential of these fibres and chrysotile fibres to induce mutations in human peripheral lymphocytes, using a mutation assay that measures mutation at the autosomal HLA-A locus. Exposure of lymphocytes in culture to 400 micrograms/ml of crocidolite or erionite for 72 hr did not result in a statistically significant increase in the mutation frequency (MF) in the HLA-A assay, although a trend towards increased MF was observed. Exposure to 400 micrograms/ml chrysotile resulted in no increase in MF; however a significant increase was observed at 50 micrograms/ml. Mutations in somatic cells can be classified according to their molecular basis. Molecular analysis of mutants obtained following exposure of lymphocytes to crocidolite and erionite demonstrated a statistically significant increase in the class of mutations arising from loss-of-heterozygosity (LOH) events involving the selection locus (HLA-A) and more distal loci. Mutations following exposure to crocidolite and erionite showed a greater frequency of LOH than did spontaneous mutants (p < 0.02 and p < 0.005 respectively). Mutants following exposure to chrysotile did not display a significant difference in LOH when compared with spontaneous mutants. Thus, although an increase in overall mutation frequency following fibre exposure did not achieve statistical significance, the modest increase seen following exposure to erionite and crocidolite is translated into a highly significant change in those components of the spectrum of mutations which result in LOH.


Assuntos
Asbesto Crocidolita/toxicidade , Asbestos Serpentinas/toxicidade , Deleção Cromossômica , Genes MHC Classe I/efeitos dos fármacos , Zeolitas/toxicidade , Alelos , Células Cultivadas , Distribuição de Qui-Quadrado , Cromossomos Humanos Par 6/efeitos dos fármacos , Clonagem Molecular , Deleção de Genes , Antígenos HLA-A/genética , Heterozigoto , Humanos , Linfócitos/efeitos dos fármacos , Mutagênese Sítio-Dirigida , Testes de Mutagenicidade , Polimorfismo de Fragmento de Restrição , Sequências Repetitivas de Ácido Nucleico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA